Hormone tied to obesity may also increase likelihood of osteoporosis
Americans who want to help maintain their mobility and independence can buy Canadian Fosamax for the treatment and prevention of osteoporosis.
Americans who want to help maintain their mobility and independence can buy Canadian Fosamax for the treatment and prevention of osteoporosis. In the interest of improving the lives of these patients, scientists continue studying this disease in order to understand what causes it. New research suggests that adiponectin, a hormone associated with obesity, may increase an individual's likelihood of developing the bone-weakening condition.
A team of scientists from the Sahlgrenska Academy at the University of Gothenburg in Sweden reviewed data taken from the Mr Os study, a program that investigates the risk factors for osteoporosis in 11,000 men from Sweden, Hong Kong and the U.S. After focusing on adiponectin, the researchers discovered that subjects who had higher levels of this hormone had less muscle mass, as well as weaker bones and muscles - all of which increase the risk of fractures, according to the team.
"High levels of adiponectin in the elderly seem to be associated with both reduced functioning of the musculature and a more fragile skeleton," said researcher Dan Mellstrom. "This means a higher risk of fractures and falls, and also increased mortality."
More than 40 million Americans are at risk for osteoporosis, if they don't already have it, according to the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a division of the National Institutes of Health.
|
